An Alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reduces the risk of macrovascular complications
It lowers blood sugar by stimulating the release of insulin by pancreatic beta cells and by inducing increased activity of intracellular insulin receptors.
Gliclazide is used for control of hyperglycemia. It is used when diabetes cannot be controlled by proper dietary management and exercise or when insulin therapy is not appropriate.